Certara, Inc. (NASDAQ:CERT) Short Interest Up 18.7% in January

Certara, Inc. (NASDAQ:CERT) saw a large growth in short interest during the month of January. As of January 31st, there was short interest totalling 5,260,000 shares, a growth of 18.7% from the January 15th total of 4,430,000 shares. Currently, 4.7% of the shares of the stock are short sold. Based on an average daily trading volume, of 1,260,000 shares, the days-to-cover ratio is presently 4.2 days.

Certara Price Performance

Shares of Certara stock opened at $14.19 on Monday. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.86 and a quick ratio of 2.86. Certara has a one year low of $9.41 and a one year high of $19.87. The stock has a market capitalization of $2.28 billion, a P/E ratio of -70.95, a price-to-earnings-growth ratio of 9.33 and a beta of 1.57. The business’s 50 day simple moving average is $12.10 and its two-hundred day simple moving average is $11.66.

Analyst Ratings Changes

A number of analysts recently weighed in on CERT shares. Barclays dropped their target price on Certara from $14.00 to $12.00 and set an “equal weight” rating for the company in a research report on Thursday, November 7th. Robert W. Baird decreased their price target on Certara from $18.00 to $13.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 5th. Six equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Certara presently has an average rating of “Hold” and an average price target of $15.92.

Hedge Funds Weigh In On Certara

Hedge funds have recently made changes to their positions in the business. Brown Brothers Harriman & Co. purchased a new position in shares of Certara during the third quarter valued at approximately $27,292,000. Kopion Asset Management LLC increased its stake in shares of Certara by 46.0% during the fourth quarter. Kopion Asset Management LLC now owns 555,643 shares of the company’s stock valued at $5,918,000 after buying an additional 175,005 shares during the period. Massachusetts Financial Services Co. MA increased its stake in shares of Certara by 40.7% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,901,898 shares of the company’s stock valued at $45,691,000 after buying an additional 1,128,006 shares during the period. Barclays PLC increased its stake in shares of Certara by 198.3% during the third quarter. Barclays PLC now owns 70,525 shares of the company’s stock valued at $825,000 after buying an additional 46,880 shares during the period. Finally, Advantage Alpha Capital Partners LP purchased a new position in shares of Certara during the third quarter valued at approximately $1,875,000. 73.96% of the stock is owned by hedge funds and other institutional investors.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.